Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Blood Advances
|
June 3, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study
Theresa Hahn, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent
Michael Ozga, Ying Huang, James S Blachly, et al.
Blood
|
February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
Parvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Haematologica
|
January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level
Naveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS
Brendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.
Leukemia & Lymphoma
|
June 12, 2024
Impact of chronic graft-<i>versus</i>-host disease on non-relapse mortality and survival
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Blood Advances
|
April 29, 2022
Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy
Max Yano, Chia Sharpe, J Rachel Lance, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Blood Advances
|
June 3, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study
Theresa Hahn, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Kendra L Sweet, Anthony S Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent
Michael Ozga, Ying Huang, James S Blachly, et al.
Blood
|
February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
Parvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Haematologica
|
January 15, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level
Naveen Pemmaraju, Marco Herling, Kendra L Sweet, et al.
Leukemia & Lymphoma
|
November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS
Brendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.
Leukemia & Lymphoma
|
June 12, 2024
Impact of chronic graft-<i>versus</i>-host disease on non-relapse mortality and survival
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Blood Advances
|
April 29, 2022
Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy
Max Yano, Chia Sharpe, J Rachel Lance, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Page
of 11